Moleculin Biotech, Inc. (MBRX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Moleculin Biotech, Inc. (MBRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.3M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 1.74 to the broader market. Moleculin Biotech, Inc. Led by Walter V. Klemp, public since 2016-06-02.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for MBRX as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →